Author:
Cai Jiumei,Wang Xiaoping,Wang Ziliang,Sheng Shanhui,Tang Fosheng,Zhang Zhiwei
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Rout, A., U.S. Tantry, M. Novakovic, A. Sukhi, and P.A. Gurbel. 2020. Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction. Expert Opinion on Pharmacotherapy 21 (15): 1851–1865.
2. Saleh M, Ambrose J. A. (2018) Understanding myocardial infarction. F1000Research 7
3. Song, J., K. Murugiah, S. Hu, Y. Gao, X. Li, H.M. Krumholz, et al. 2021. Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China. Heart 107 (4): 313–318.
4. Yu, C., F. Zhang, L. Zhang, J. Li, S. Tang, X. Li, et al. 2023. A bioinformatics approach to identifying the biomarkers and pathogenesis of major depressive disorder combined with acute myocardial infarction. American Journal of Translational Research. 15 (2): 932.
5. Zhao, C., J. Liu, W. Ge, Z. Li, M. Lv, Y. Feng, et al. 2021. Identification of regulatory circRNAs involved in the pathogenesis of acute myocardial infarction. Frontiers in Genetics 11: 626492.